Diabetes drug could reduce heart failure in cancer survivors

Diabetes drug could reduce heart failure in cancer survivors

A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research from the University of East Anglia.

1. Diabetes Drug Reduces Heart Failure Risk in Cancer Patients by 50% – A Game-Changer for Recovery

A widely used diabetes medication, SGLT2 inhibitors, has shown a surprising benefit for cancer patients—protecting their hearts from chemotherapy-related damage. Researchers found that it slashes heart failure risk and hospitalizations by over 50%, with particularly strong effects in breast cancer patients. A widely used diabetes medication may help cancer patients recover more effectively in the [...]

Medtronic Insulin Pump Air Pressure Issues Could Lead to Dangerously Low Blood Sugar Levels

Federal health officials have issued a recall for 41,404 Medtronic MiniMed insulin pumps after discovering a risk of delivering incorrect insulin doses due to air pressure fluctuations, such as those experienced during airplane takeoff and landing. Medtronic MiniMed insulin pumps are medical devices used by people with diabetes to help manage blood sugar levels. They deliver a continuous supply of insulin throughout the day and additional doses …

Study shows diabetes drug may reduce heart failure risk in cancer...

Last Updated on March 6, 2025 by New Delhi, March 6 (IANS) A common type of diabetes medication may help cancer patients ward off the risk of heart failure by 50 per cent and boost long-term recovery, according to new research on Thursday. Heart failure is common among cancer patients, and can lead to a […] The post Study shows diabetes drug may reduce heart failure risk in cancer patients by 50 pc appeared first on THIP Media.

Study: Diabetes drug may cut heart failure risk in cancer patients by 50%

A common type of diabetes medication may help cancer patients ward off the risk of heart failure by 50 per cent and boost long-term recovery, according to new research on Thursday.

Drug Repurposing: Finding New Roles for Old Medicines

While drug repurposing is generally faster and cheaper than drug development ‘from scratch’, we face numerous challenges along the way, including low financial incentives for companies and suboptimal legislation for adding new indications to existing drug labels. In this article, we talk to the Anticancer Fund, a Brussels-based non-profit organization that works with universities, hospitals, and researchers to investigate new cancer treatments a…